Precision Medicine Offers Belatacept Monotherapy (PROBE)

Trial Profile

Precision Medicine Offers Belatacept Monotherapy (PROBE)

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 24 Oct 2016

At a glance

  • Drugs Belatacept (Primary)
  • Indications Renal transplant rejection
  • Focus Adverse reactions
  • Acronyms PROBE
  • Most Recent Events

    • 24 Oct 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top